GEN Exclusives

More »

GEN News Highlights

More »
Jun 18, 2014

NSF and NIH Set Up Commercial Boot Camp for Researchers

  • The National Science Foundation (NSF) and the National Institutes of Health established a collaboration designed to give NIH-funded researchers training to help them evaluate their scientific discoveries for commercial potential. The aim is to accelerate biomedical innovations into applied health technologies.

    I-Corps at NIH is a pilot of the NSF Innovation Corps program specially tailored for biomedical research. Academic researchers and entrepreneurs with Small Business Innovation Research and Small Business Technology Transfer Phase I awards from participating NIH institutes will be eligible to apply to I-Corps at NIH. NIH will begin outreach to the small business research community with a June 25 program briefing at the 2014 BIO International Convention in San Diego, and a webinar on July 2.

    The I-Corps Teams curriculum is a nine-week boot camp in which experienced business-savvy instructors work closely with teams of researchers to help them explore potential markets for their federally funded innovations. I-Corps instructors take a scientific method-based approach to customer discovery that resonates with scientists and engineers. While I-Corps instructors typically have a wide range of expertise, I-Corps at NIH will be taught by instructors who have biomedical business experience.

    For more information about NSF I-Corps, visit http://www.nsf.gov/news/special_reports/i-corps


Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

New Drugs for Ebola

Do you think that biopharma companies should not have to go through the normal drug approval process in order to get potential life-saving therapies to Ebola patients more quickly?